Vigabatrin Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Vigabatrin Tablet (tablet) from Hikma Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on Oct 16, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0054-0652-25
- Dosage Form
- Tablet
- Presentation
- Vigabatrin, Tablet, 500 mg (NDC 0054-0652-25)
- Initial Posting
- Oct 16, 2026